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The behaviour of protonated ractopamine (RacH+) at an array of micro-interfaces between two 
immiscible electrolyte solutions (micro-ITIES) was investigated via cyclic voltammetry (CV) and 
linear sweep stripping voltammetry (LSSV). The micro-ITIES array was formed at silicon 
membranes containing 30 pores of radius 11.09 ± 0.12 µm and pore centre-to-centre separation 
of 18.4 ± 2.1 times the pore radius. CV shows that RacH+ transferred across the water 1,6-
dichlorohexane µITIES array at a very positive applied potential, close to the upper limit of the 
potential window. Nevertheless, CV was used in the estimation of some of the drug’s 
thermodynamic parameters, such as the formal transfer potential and the Gibbs transfer energy. 
LSSV was implemented by pre-concentration of the drug, into the organic phase, followed by 
voltammetric detection, based on the back-transfer of RacH+ from the organic to aqueous 
phase. Under optimised pre-concentration and detection conditions, a limit of detection of 0.1 
µM was achieved. In addition, the impact of substances such as sugar, ascorbic acid, metal 
ions, amino acid and urea on RacH+ detection was assessed. The detection of RacH+ in 
artificial serum indicated that the presence of serum protein interferes in the detection signal, so 
that sample deproteinisation is required for feasible bioanalytical applications.  
 







Ion transfer across the interface between two immiscible electrolyte solutions (ITIES) [1-4] 
has received increasing interest in the field of electrochemistry, liquid  liquid extraction and 
membrane transport. Electrochemistry at liquid  liquid interfaces has moved from the transfer of 
model ions such as tetraalkylammonium ions to the detection of molecules of biological 
importance such as proteins, peptides, amino acids, drugs, neurotransmitters, food additives 
and DNA [5]. Thus it plays a potentially important role in new bioanalytical methods.  
Ractopamine (Rac) (Fig. 1(a)) is a phenyl -ethanolamine, with -adrenergic agonist 
properties [6-9]. It is primarily used as a therapeutic drug for treatment of pulmonary diseases 
such as asthma in human and veterinary medicine [6, 7]. Unfortunately, this substance is also 
illegally applied in the livestock industry as a nutrient repartitioning agent. Research shows that 
-agonists divert fat deposition to the production of muscle tissues by increasing nitrogen 
retention, protein synthesis and lipolysis [6, 7, 9-11]. It also improves growth rate and feed 
conversion when fed to livestock (such as calves, poultry etc.) [8, 9, 12]. Recently, veterinary 
drug residues have become a public food safety concern where ractopamine-treated animals 
may pose adverse effects on human health, especially in the cardiovascular and central 
nervous systems [6, 7, 9, 12, 13]. Thus, it is banned in many countries, including within the 
European Union and China, although it is approved by the United States’ Food and Drug 
Administration (U.S. FDA) [12, 14-16]. As a result, rapid, simple and sensitive analytical 
methods for the detection of ractopamine residues are required. 
To date, various analytical methods have been reported for the detection of ractopamine, 
such as immunoassays [9, 10, 17], electrochemical methods [6, 7, 13, 16], gas 
chromatography-mass spectrometry [11], liquid chromatography tandem mass spectrometry 
[12, 18] and high performance liquid chromatography [8, 14, 15]. Electrochemical methods offer 
the advantages of low instrumental cost and fast analysis, and thus may be the preferred 
methods in ractopamine detection [7]. Despite the fact that many electrochemical methods have 
been developed, those studies focused on solid  liquid interfaces, using primarily cyclic 
voltammetry (CV) [6, 7, 16]. The two phenolic groups in ractopamine are easily oxidised [6, 7, 
13]. Differential pulse voltammetry (DPV) has also been employed for the detection of 
ractopamine [6, 7, 13].  
To the best of our knowledge, no studies have been reported on the electrochemical 
detection of ionised ractopamine based on transfer across the ITIES. Thus, this study opens up 
the possibilities for the detection of ractopamine based on charge transfer across micro-ITIES. 
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However, the detection of other drugs at the ITIES via various electrochemical methods has 
been reported in the literature, namely the anticancer drug daunorubicin at a microporous 
polyethylene terephthalate (PET) membrane-supported ITIES [19], catamphiphilic drugs at a 
solvent polymeric membrane [20], and β-blocker drugs (propranolol, timolol and sotalol) at a 
microporous silicon membrane-supported ITIES [21]. Besides analytical studies, the ability of 
the ITIES to mimic the drug transfer across biological membranes has offered insight into 
mechanisms of drug action [19]. Voltammetry at the ITIES has been used to investigate the 
transfer characteristics of charged drug molecules, for example, the Galvani potential difference 
(∆𝑜
𝑤∅) for the ion transfer and the Gibbs energy of transfer, which is directly related [22]. 
Previous studies by Girault and co-workers [23, 24] have shown that the ITIES is a suitable 
platform for the determination of the partition coefficient of the ionised species, which in turn 
defines the drug’s lipophilicity in biological systems [19, 20, 22]. 
Direct drug detection in physiological matrices, such as blood and blood-derived samples, is 
important because it offers information regarding circulating levels. Yet, this can be hindered 
due to drug-protein binding [25]. The drug-protein interaction in blood plays an important role in 
determining drug transportation, absorption, distribution, metabolism and excretion [26-28]. 
Serum albumins are present at the highest abundance in blood (ca. 60 % of the total albumin) 
[29, 30], and these proteins exhibit high affinity towards drugs [26-28, 31]. In addition, the 
pharmacological activity of drugs relates to their free concentration in blood [25]. The 
measurement of drug-protein interactions has seen the emergence of a number of novel label-
free strategies [32]. In this study, albumin from bovine serum (BSA) is employed due to the fact 
that human and bovine serum albumins are homologous proteins [29, 33, 34]. BSA is a highly 
water-soluble globular protein, which has a molar mass of 69,000 amu and a hydrodynamic 
radius of ca. 3.25 nm [25, 35]. BSA also has a low isoelectric point (pI of  5.4) and high negative 
net charge at neutral pH [36].  
In this report, emphasis is placed on the electrochemical behaviour of protonated 
ractopamine (RacH+) at the micro-ITIES array. Quantitative methods that involve the detection 
of RacH+ by simple ion transfer at the water  1,6-dichlorohexane (DCH) micro-interface array 
are presented, using CV and linear sweep stripping voltammetry (LSSV). Stripping analysis at 
micro-liquid  liquid interface arrays is appropriate for analyte detection in media such as 
biological fluids, soil extracts and water [37], thus this technique is examined in this study. The 
thermodynamic parameters for the transfer of ionisable ractopamine are discussed. In addition 
to the analytical parameters, the influence of the interfering substances, including serum 








All reagents used were purchased from Sigma-Aldrich Pty. Ltd., Australia and used without 
further purification, unless stated otherwise. D-Glucose and sodium chloride (NaCl) were 
purchased from Ajax Finechem Pty. Ltd., Australia, L-ascorbic acid and potassium phosphate 
monobasic (KH2PO4) from BDH Laboratory Supplies, Australia, and sodium sulfate (Na2SO4) 
from Chem-Supply Pty. Ltd, Australia. 
The aqueous phase solution of 10 mM lithium chloride (LiCl) was prepared in ultrapure 
water (resistivity of 18 M cm) from a Milli-Q water purification system (Millipore Pty. Ltd., North 
Ryde, NSW, Australia). The organic electrolyte salt was prepared by metathesis of 
bis(triphenylphosphoranylidene)ammonium chloride (BTPPACl) and potassium  tetrakis(4-
chlorophenyl)borate (KTPBCl). The organic phase was mechanically stabilized as a polymer gel 
[38-41] and was composed of the supporting electrolyte (10 mM BTPPATPBCl) and low 
molecular weight poly(vinylchloride) (PVC) (10 % w/v), dissolved in 1,6-dichlorohexane. Prior to 
the experiments, both the aqueous and organic phase solvents were mutually pre-saturated. 
The organic reference solution consisted of 10 mM BTPPACl dissolved in 10 mM LiCl 
(aqueous). Ractopamine hydrochloride and tetrapropylammonium chloride (TPrACl) served as 
the drug and model analyte species studied, respectively. A stock solution of TPrACl was 
prepared in 10 mM LiCl while the stock solution of ractopamine hydrochloride was prepared in 
methanol (MeOH) due to its low solubility in water [15]. 
In the interfering substances study, the interferents were prepared in 1 mM PBS solution as 
the supporting electrolyte, which contained 1 mM phosphate buffer, 0.27 mM potassium 
chloride (KCl) and 13.7 mM NaCl. D-Glucose, L-ascorbic acid, KCl, NaCl, Na2SO4, glycine and 
urea were the interfering substances studied, and the concentration of each of these was fixed 
at 5.0 mM. The effect of artificial serum matrix [25, 42, 43] on the detection of RacH+ was also 
investigated. The artificial serum used was composed of 1.5 mM KCl, 5.0 mM calcium chloride 
(CaCl2), 1.6 mM magnesium chloride (MgCl2), 4.7 mM D-glucose, 1.0 mM sodium phosphate 
monobasic (NaH2PO4), 1.0 mM KH2PO4, 2.5 mM urea and 0.6 mM bovine serum albumin, 





2.2. Preparation of micro-interface arrays 
 
The micropore arrays used for micro-ITIES patterning were fabricated in 100 µm thick 
silicon membrane by lithographic patterning and wet and dry silicon etching methods at Tyndall 
National Institute, University College Cork, Cork, Ireland [41]. The micropores are depicted in 
Fig. 1 (b) and (c), with 11.09 ± 0.12 µm radius, 𝑟𝑎, 30 pores in a hexagonal close-packed 
arrangement, and with pore centre-to-centre separation, 𝑟𝑐, of 18.4 ± 2.1 times the pore radius, 
𝑟𝑎 (i.e. 𝑟𝑐 = 18.4𝑟𝑎). The silicon chip (5 mm  5 mm) was sealed onto the lower orifice of a 
cylindrical glass tube (𝑑𝑖𝑛𝑛𝑒𝑟= 2.5 mm, 𝑑𝑜𝑢𝑡𝑒𝑟= 4.0 mm) using silicone rubber sealant (Selleys, 
Australia and New Zealand) and allowed to cure for 72 hours before use. The membrane was 
cleaned with acetone and dried in air before and after each electrochemical experiment. All the 
experiments were conducted at room temperature (20 C). 
 
2.3. Experimental procedure at the micro-ITIES array 
 
The electrochemical techniques were performed using an Autolab PGSTAT 302N (Metrohm, 
The Netherlands) together with the Nova 1.7 or Nova 1.8 software supplied with the instrument. 
The electrochemical cell was housed in a Faraday cage for the duration of the experiment to 
minimize electrical noise. A two-electrode electrochemical cell was employed in this study since 
the 𝐼𝑅 drop effect at micro-ITIES system is not too high as compared to macro-ITIES system 
[44]. Both AgAgCl electrodes served as reference and counter electrodes in either phase. The 
applied potential, 𝐸, is defined as the potential difference between the two electrodes, with 
positive current due to the transfer of cations from the aqueous to the organic phase [20]. 
The borosilicate glass tube with membrane sealed to one end with silicone sealant 
contained 100 L of the gellified-organic phase and 200 L of the organic reference solution. 
This was then immersed in 6 mL of the aqueous phase solution in a 10 mL glass beaker. The 
electrochemical cells employed in this study can be schematically summarized as follows: 
AgAgClx M ractopamine HCl + 10 mM LiClW10 mM 
BTPPATPBClDCH10 mM BTPPACl in 10 mM LiClWAgClAg 
Cell 1 
AgAgCl0.1 mM ractopamineHCl + 5 mM interfering substance + 10 mM 






AgAgClx M ractopamine HCl + artificial serumW10 mM 
BTPPATPBClDCH10 mM BTPPACl in 10 mM LiClWAgClAg 
Cell 3 
where x is the concentration of ractopamine in the aqueous phase. In every electrochemical 
cell, TPrA+ was spiked into the aqueous phase after the final RacH+ or interferent injection, as a 
control of the potential axis. 
Prior to the injection of analyte into the aqueous phase with a micropipette to achieve the 
required concentration, a background CV at 5 mV s-1 was recorded over a wide potential range 
so as to establish the limits of the available potential window. A quiet time of 5 s at the initial 
potential of each scan was implemented. In LSSV, the parameters pre-concentration potential, 
pre-concentration time and sweep rate were explored to determine the optimum values, and 
these were implemented in subsequent experiments. 
 
3. Results and discussion 
 
3.1. CV at the micro-ITIES array 
 
CV profiles of 20 to 100 µM RacH+ at the gelled micro-ITIES arrays (Cell 1) are presented in 
Fig. 2 (a) and (b), in the form of experimental data and background-subtracted voltammograms, 
respectively. The p𝐾𝑎 of the amine group in ractopamine is 9.4 [8], so that in the aqueous phase 
used in this work, 10 mM LiCl (pH  6) [19, 21], the drug is cationic. The CVs show that RacH+ 
ions, which are initially present in the aqueous phase, are transferred into the gelled organic 
phase under potential control, on the forward CV sweep. These ions are transferred back from 
the organic into the aqueous phase, during the reverse scan.  
The shape and magnitude of the voltammetric response are highly dependent on factors 
such as the diffusion regime shape, the position of the ITIES within the pores, the properties of 
the electrolyte solutions and of the transferring ion species, and the magnitude of the diffusion 
zone extension () [45, 46]. The interfaces employed here were inlaid so that each pore was 
filled with the organic electrolyte solution and the interface was at the aqueous side of the 
membrane [45]. Generally, for an inlaid micro-ITIES array, steady-state voltammograms are 
obtained in the forward CV sweep, indicating establishment of radial diffusion fields, while peak-
shaped voltammograms are obtained on the reverse scans, attributed to linear diffusion control.  
However, in this study, the CVs on the forward scan show that the foot of the ion transfer 
wave was at a very positive applied potential difference (0.8 V), close to the upper limit of 
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potential window (Fig. 2(a)). The current increased steadily with applied potential up to the 
switching potential, so that a fully-develop stead-state wave shape was not obtained. On the 
reverse scan, a peak-shaped feature was observed, due to the transfer of RacH+ ions which 
had been retained within the micropores. The incorporation of PVC in the organic phase 
increases the viscosity, and hence slows down rate of diffusion of ions in the organogel [45], so 
that the diffusion coefficient of a target analyte in the gelled organic phase may be ca. nine-
times lower than in the aqueous phase [45].  
The background-subtracted currents on the forward and reverse scans (Fig. 2(b)) increased 
linearly with RacH+ concentration in the aqueous phase, with the maximum currents chosen to 
construct the calibration graphs of the forward scan (Fig. 2 (c)). Theoretically, the current of the 
forward scan can be modelled by the Saito equation [47, 48] if a steady-state current (radial 
diffusion control) had been achieved. At the ITIES, the potential window is restricted by the 
transfer of background electrolyte ions [5]. However, in this study it was found that RacH+ 
transfer occurred at a potential just below the transfer of the background electrolytes and 
steady-state current for RacH+ transfer was not achieved. 
Following the final RacH+ experiment, 100 µM TPrA+ was spiked into the aqueous phase 
(Fig. 2 (a) inset – top, and (b) inset) as a model ion and a potential axis reference ion [19, 49]. 
The resulting CV showed a steady-state behaviour on the forward scan, while the reverse scan 
demonstrated a peak shape, in agreement with previous experiments and computer simulations 
[45]. This micro-ITIES array thus displayed the expected mass-transport behaviour. The foot of 
the ion transfer wave, and the half-wave potential were observed at approximately 0.45 V and 
0.52 V, respectively, in agreement with previous studies [25, 48]. The formula to calculate the 
steady-state current (limiting current) for ion transferring from the aqueous to the organic phase 
is given by the Saito equation modified for the number of micropores in the membrane [47]: 
𝐼𝑠𝑠 = 4𝑧𝐹𝐷𝐶𝑟𝑎𝑁𝑝           (1) 
where 𝐼𝑠𝑠 is the steady-state current, 𝑧, 𝐷 and 𝐶 are the charge, diffusion coefficient and bulk 
concentration, of the transferring ions in the aqueous phase, correspondingly. 𝐹 is the Faraday 
constant (96,487 C mol-1) and 𝑁𝑝 is the number of micropores. The steady-state experimental 
current was within ca. 10 % of the current obtained from Eq. (1). This may indicate that the 
interfaces formed at the micropore mouths were not flat, in turn enhancing the radial diffusion to 
the interfaces so that the current is increased. The steady-state current for radial diffusion to an 
array of hemispherical micro-ITIES is given by [50, 51]: 
𝐼𝑠𝑠 = 2𝜋𝑧𝐹𝐷𝐶𝑟𝑎𝑁𝑝           (2) 
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However, in this case the experimental current was ca. 30 % lower than that calculated from Eq. 
(2). This indicates that the µITIES were closest to inlaid microinterface behaviour.  
There is a lack of information in the literature on the diffusion coefficient of ractopamine. 
Attempts to determine this from the oxidation response at glassy carbon electrode were not 
successful, due to the problems associated with fouling of the surface, probably by the 
adsorption of either the drug or its oxidation products. A similar fouling problem was reported 
previously for salbutamol oxidation at glassy carbon electrodes [52]. Therefore, an assumption 
of the diffusion coefficient value was made based on the published data for salbutamol sulfate 
(𝐷 = 3.3  10-6 cm2 s-1) [53], since ractopamine and salbutamol are a group of -adrenergic 
agonist which possess similar chemical structures and functions [16]. Use of this value in Eq. 
(1) produced a steady-state current for the transfer of RacH+ across microITIES array that was 
lower than the maximum current in the forward scan, suggesting the need for an accurate 
diffusion coefficient value. 
A final control experiment was the impact of methanol on the CV, because the ractopamine 
stock solution was prepared in MeOH (see lower inset in Fig. 2 (a)). The same injection volume 
used to prepare 20 to100 µM of analyte was applied. It was observed that the addition of MeOH 
had no observable effect on the analyte CV.  
 
3.2. Thermodynamic parameters of RacH+ transfer at the water  DCH interface 
 
A number of thermodynamic parameters for the drug transfer were determined from the CV 
data. These are listed in Table 1. 
The value of the formal transfer potential of an ionised drug is obtained by transposing the 
measured experimental value to the Galvani potential scale, as given by the following 
expression [54-58]:  
𝐸1/2 (drug) − ∆𝑜
𝑤∅0
′








(TPrA+) is the formal transfer potential of the TPrA+ ion. 𝐸1/2 (drug) and 
𝐸1/2 (TPrA
+) are the experimental half-wave potentials of the drug and TPrA+ transfer, 
respectively. In this study, a value of -0.086 V was used for ∆𝑜
𝑤∅0
′
(TPrA+) [59]. TPrA+ ion was 
selected as a model ion since the transfer potential differs from that of RacH+ and there is no 
mutual interference. 
The Gibbs energy of transfer is directly related to the formal transfer potential of the ion 
transfer [60]. The ability to measure this value depends on the condition that the transferring ion 
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has a lower magnitude of the Gibbs transfer energy than the ions of the supporting electrolytes 
[58, 61]. However, for RacH+, the ion of interest transfers at the upper limit of the potential 
window so that the experimental measurement of the half-wave potential (𝐸1/2 (drug)) was not 
possible. A similar observation was reported by Osborne and Girault [58] for the transfer of 
ammonium ions across a water  1,2-dichloroethane (DCE) interface and by Cacote et al. [62] 
for the direct transfer of Ag+ ions across a water  DCE interface. A method to determine the 𝐸1/2 
of the species limiting the potential window was developed by Shao et al. [61], which was based 
on a set of simulated CVs in which the switching potential is set prior to the forward peak 
potential. The half-wave potential of the species limiting the potential window was then 
determined from the resultant working curve, which was a plot of 𝐼𝑒𝑜𝑠 𝐼𝑟𝑝⁄  versus 𝐸𝑟𝑝 − 𝐸1 2⁄ , 
where 𝐼𝑒𝑜𝑠 and 𝐼𝑟𝑝 are the current at the end of the forward scan and the return peak current, 
respectively, 𝐸𝑟𝑝 is the return peak potential and 𝐸1 2⁄  is the half-wave potential. However, the 
published working curve applied was developed for an ITIES subjected to linear diffusion on 
both forward and reverse transfer processes and hence is not applicable to the present 
situation. Our approach was to compare the shape of the experimental CV for RacH+ transfer to 
that for TPrA+ transfer recorded with different switching potentials [63, 64]. Finding a shape for 
the model ion transfer process which match to that for RacH+, by visual comparison, allowed the 
𝐸1 2⁄  for the ionised drug transfer to be determined by assuming that similar current ratios and 
potential ratios apply to both ions (i.e. that they have similar transfer kinetics and are not 
distorted by experimental variables such as cell resistance and capacitance). The 𝐸1 2⁄  of the 
RacH+ ion was estimated in this way to be 0.9 V. Taking into account the assumption that 
Walden’s rule (𝐷𝑜 𝐷𝑤⁄ = 𝜂𝑤 𝜂𝑜⁄ ) applies to the transfers of RacH+ and TPrA+, the Galvani 
transfer potential of RacH+ is obtained using Eq.(3)  to be 0.29 V (Table 1) [58].  








           (4) 
where ∆𝐺𝑡𝑟
0′,𝑤→𝑜
 is the formal Gibbs transfer energy of ion from the aqueous (w) to the organic 
(o) phase. The calculated value is presented in Table 1. The formal Gibbs energy of transfer of 
RacH+ was 27.9 kJ mol-1 across a water  DCH interface. Values of 18.3 kJ mol-1 and 7.7 kJ mol-
1 have been reported previously for protonated pyridine (PyH+) transfer across a water  2-
nitrophenyl octyl ether (NPOE) interface, and protonated quinidine (QH+) transfer across a 
water  DCE interface, respectively. 
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Another important thermodynamic parameter is the partition coefficient (log 𝑃) of a given 
solute between two immiscible solvents. This is a measurement of its relative affinity  for the two 
phases, and is related to the free energy of transfer of the solute between the two solvents [24, 
65]. The measurement of the ionised drug partition coefficient is vital since most drugs (>70 %) 
are ionisable under physiological conditions [44]. In this case, the partition coefficient of RacH+ 
between water and DCH is obtained from Eq. (5) [19, 44, 60]:  
log 𝑃𝐷𝐶𝐻




         (5) 
where 𝑅 is the gas constant (𝑅 = 8.31 J K-1 mol-1) and 𝑇 is the temperature in kelvin. The 
partition coefficient of the RacH+ was -4.9 (Table 1), while the value for DNRH+ was -8.0 [19], 
both for the water  DCH system. Comparison of the partition coefficients of the neutral form of 
both drugs in 𝑛-octanol-water systems shows that the log 𝑃𝑛−𝑜𝑐𝑡
0  value for daunorubicin was 
higher than that for ractopamine, meaning that ractopamine is more hydrophilic, since a lower 
partition coefficient value indicates a more hydrophilic property [19]. A review of the 
electrochemical investigations made on the transfer of ionisable drugs at ITIES to determine 
their partition coefficients employing voltammetric methods for water  nitrobenzene (NB), water  
NPOE, and water  DCE systems does not include any data for the water | DCH system [22], as 
this has been introduced only relatively recently [59].  
 
3.3. Optimisation of the LSSV parameters for the detection of RacH+ 
 
In order to detect lower concentrations, LSSV was employed, as this entails a pre-
concentration step that enhances sensitivity. In the pre-concentration step, RacH+ was 
extracted from the aqueous to the organogel phase under potential control. Then, the pre-
concentrated analyte was stripped out of the organogel using a voltammetric scan [21, 37]. The 
pre-concentration step is important in LSSV as it enables the detection of lower concentrations 
relative to CV. This stripping analysis method is reported to offer greater sensitivity and lower 
detection limits, down to nanomolar and parts per billion levels [37]. As a result, the optimisation 
of LSSV parameters, namely the sweep rate, the pre-concentration potential and the pre-
concentration time, was explored, employing Cell 1. Voltammetric scans were conducted in the 
negative direction, from 1.0 to 0.4 V. 
To assess the impact of sweep rate on the results (figure not shown), the sweep rate value 
was varied between 5 and 100 mV s-1, using 100 µM RacH+. The pre-concentration potential 
was fixed at 1.0 V while the pre-concentration time was set at 60 s. A blank LSSV was recorded 
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in the absence of analyte, so that background-subtracted LSSV could be obtained by 
subtracting the blank response from that of the analyte. The stripping peak current was found to 
be linearly-dependent on the square root of the sweep rate, indicating a linear diffusion-
controlled organic phase to aqueous phase transfer process [41]. Despite this result, it was 
found that lower sweep rates produced a more clearly-defined peak shape, consistent with peak 
distortion by cell resistance and capacitance at the higher sweep rates. Consequently, all 
subsequent experiments employed a sweep rate of 5 mV s-1 since this sweep rate produced a 
well-defined peak shape with less sensitivity to these distortions. 
The influence of the pre-concentration potential was studied by employing 20 µM RacH+ 
with a 60 s pre-concentration time, while varying the pre-concentration potential from 0.60 to 
1.00 V in increment of 0.05 V (Fig. 3). From the inset graph, it can be seen that the stripping 
peak current only appeared when the pre-concentration potential was higher than 0.85 V. As 
observed earlier by CV, RacH+ transfers at an applied potential very close to upper limit of the 
potential window. The maximum stripping peak current was observed when the pre-
concentration potential was 1.00 V, thus this potential was applied for all subsequent 
experiments. 
The influence of pre-concentration time was studied at 1.00 V pre-concentration potential 
using 100 µM RacH+, with variations in the pre-concentration time from 15 s to 180 s. Over the 
time range of 0-1 min, the increment was 15 s, while in the range 1-3 min, the time increment 
was increased to 30 s (Fig. 4). The stripping peak current increased as the pre-concentration 
time increased, eventually reaching a constant value, as illustrated in the inset graph. This 
effect was reported previously for the detection of propranolol [21] and oligopeptides [39] at the 
micro-ITIES array, and was attributed the diffusion of analyte away from the interface to the bulk 
organic phase during the longer pre-concentration times. Therefore, during stripping step, these 
analytes are not stripped back to the aqueous phase and do not contribute to the stripping peak 
[37]. The optimum pre-concentration time of 120 s was selected and applied in all subsequent 
experiments.  
  
3.4. LSSV analysis at the micro-ITIES array 
 
Employing all of the optimised parameters (5 mV s-1 sweep rate, 1.00 V pre-concentration 
potential, 120 s pre-concentration time), low concentrations of RacH+ in the range 0.1-1.0 µM 
were analysed and a calibration graph was plotted of stripping peak current versus 
concentration of RacH+ (Fig. 5). The increase in RacH+ concentration resulted in an increase of 
the stripping peak current, with a linear concentration dependence observed within the range 
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studied, (𝐼𝑝 = -0.2718 (nA µM
-1) (concentration) - 0.0974 (nA), 𝑅 = 0.9964, 𝑛 = 6). The 
calculated limit of detection (LOD) is 0.1 µM (34 ng mL-1), based on 3 times the standard 
deviation of the blank (3𝑠𝑏) [66]. This compares well with previously published values. LODs of 
1.17 µM (CV and electrochemical impedance spectroscopy at a modified electrode) [67], 0.06 
µM (DPV at a carbon nanotube-modified glassy carbon electrode (GCE)) [6], 0.05 µM (DPV at a 
graphene oxide-modified GCE) [13], and 0.06 µM (DPV at an ordered mesoporous carbon-
modified GCE) [7] have been reported for ractopamine.  
   
3.5. Influence of potentially interfering substances 
 
Possible interferences in the detection of RacH+ were investigated using substances such 
as a sugar, ascorbic acid, metal ions, an amino acid and urea [6, 7, 19, 68]. These substances 
were selected since they are all models of substances likely to be present in a biological 
sample. This study was conducted using CV. The aqueous phase of the electrochemical cell 
(setup as in Cell 2) was spiked with the RacH+ and individual interference substances at 
concentrations of 0.1 mM and 5.0 mM, respectively. The current signal for 0.1 mM RacH+ was 
individually measured in the absence and presence of the interfering substances, and the 
current change was then determined. In addition, TPrA+ was spiked to every aqueous test 
phase as a model ion and a potential axis reference ion. The results obtained are summarised 
in Fig. 6 and in Table 2. 
Glucose was chosen as a model of possible sugar interference. Since it is an uncharged 
molecule and hence does not provide a current for transfer across the water  DCH interface, it 
is not expected to impact on the detection of RacH+ since no ion transfer signal was detected 
(Fig. 6 (a)). The potential interference of ascorbic acid was also investigated, and no transfer of 
ascorbate was observed (Fig. 6 (b)). Ascorbic acid (p𝐾𝑎 of 4.17 [19]) was de-protonated in the 
aqueous phase. The possible interference of metal ions such as K+ and Na+ were also 
evaluated. Metal ions, in particular K+ and Na+, are expected to transfer at the positive end of 
the potential window, which results in a decrease of the potential window [19, 49, 69]. Additions 
of KCl (Fig. 6 (c)), NaCl (Fig. 6 (d)) and Na2SO4 (Fig. 6 (e)) to the aqueous phase did alter the 
RacH+ ion transfer signal, in agreement with previous reports [19, 69], with KCl having the 
greatest impact. Glycine was used as a model amino acid interferent and is widely reported in 
interference studies [6, 7, 19]. At physiological pH, glycine is a net neutral molecule hence it 
should not show any ion transfer behaviour at the interface (Fig. 6 (f)) [19]. However, there was 
a slight increase in current at the positive end of the potential window when glycine was added. 
Note that although amino acids can be transferred across the ITIES [70], a low pH (pH  1.0) is 
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required to ensure complete protonation of the amino acid,  and an ionophore must be used to 
facilitate the transfer process. The possible interference of urea was also investigated (Fig. 6 
(g)). Urea did not show a transfer signal at the interface, since it is a neutral compound [71]. In 
addition, a control experiment to assess the impact of the PBS solution on the interfering 
substance CVs was conducted, since all the interfering substance stock solutions were 
prepared in PBS solution (Fig. 6 (h)). The same injection volume as used to prepare 5.0 mM of 
interfering substance was applied. The addition of PBS was observed to have a minimal impact 
on the interfering substance’s CV. 
The current changes in the presence of interfering substances (% Relative difference, Table 
2) were in the range of 6.2 to 19.2 %, and 0.7 to 16.1 %, based on the forward and reverse scan 
currents of RacH+, respectively. The forward current is more sensitive to the presence of 
potentially-interfering substances than the reverse scan. Substances not expected to interfere 
produced a 10 % current increase in the forward scan. For both scans, KCl (Fig. 6 (c)) 
demonstrated the highest current change. In all cases, the results exhibited 3 % relative 
standard deviation (% RSD) from repeated measurements on a single electrochemical cell (n = 
3). Table 2 also summarises the total variation in the RacH+ signal in the absence of potentially 
interfering substances (% RSD of 15.3 % and 16.9 % for the forward and reverse scans, 
respectively), which reflects the experimental day-to-day reproducibility of the experiments.  
In addition, the background current signal demonstrated % RSD of 16.3 %, 19.3 % and 10.3 
%, measured at the minimum, maximum and within the ‘polarisation range’ (at 0.6 V) potentials, 
respectively, based on the blank CVs shown in Figure 6. On the other hand, the TPrA+ current 
signal demonstrated % RSD of 15.8 % and 12.7 %, measured at the minimum reverse peak 
and maximum forward current for this ion ( 0.6 V), respectively. Again, the variation in signals 
reflects the day-to-day reproducibility within the experiments.   
Based on these observations, only potassium was seen to have a major impact on the 
detection of RacH+, and none of the other substances produced ion transfer peaks. 
Furthermore, since the reverse peak is less impacted than the forward current, use of a 
stripping voltammetry approach is suggested. 
 
3.6. Determination of RacH+ in artificial serum  
 
The determination of RacH+ in artificial serum as the aqueous phase electrolyte solution was 
conducted using Cell 3. In this study, two types of artificial serum solutions were prepared; the 
first contained no BSA, while the second contained BSA at physiological concentration. These 
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solutions were utilised to investigate the possibility that BSA can impede the detection of RacH+, 
as reported previously for other ionised drugs at the ITIES [25, 35].  
Several ways have been identified for BSA to hinder the detection process: potential window 
shortening, drug-protein binding [25, 72] or protein adsorption at the interface [25, 35]. BSA is a 
water-soluble globular protein which has a net charge of 17 at physiological pH (of 7.4) [36], 
while RacH+ has a charge of +1. These opposite charges contribute to ractopamine-albumin 
binding, although the binding effect will reduce through shielding from the electrolyte ions. 
Zhang et al. [72] reported that ractopamine bound to BSA mainly by electrostatic and 
hydrophobic interactions. The formation of the ractopamine-albumin complex was spontaneous 
and the strong interactions indicated that the drug has a long residence time in blood plasma. 
Additionally, BSA may adsorb to the ITIES. Collins et al. reported that BSA diminished the 
signal of ionised propranolol in artificial serum, although detection was still possible [25]. 
Vanysek and Sun demonstrated that the transfer of Cs+ ion across a water  NB interface was 
inhibited by the adsorption of BSA on the interface [35]. Plasma proteins such as albumin have 
been reported to be a major source of interference in plasma measurement at the ITIES [19, 
73].  
CV of the two artificial serum matrices was carried out with the addition of 100 µM RacH+. 
Prior to that, a background CV was run over a wide potential range to establish the limits of the 
available potential window (Fig. 7 (a) and (b)). Incorporation of BSA in the artificial serum 
decreased the width of the potential window to 850 mV, from 950 mV in its absence. Since BSA 
shortened the potential window at the upper limit (Fig. 7 (b)), the detection of ractopamine might 
be hindered as RacH+ transfers at a very positive applied potential difference, close to the upper 
limit of the potential window, in the LiCl solution. It was observed that the RacH+ transfer was 
possible in artificial serum without BSA. The protonated drug transferred close to the positive 
limit of the potential window on the forward scan, while on the reverse scan, a peak-shaped 
feature was obtained (Fig. 7 (c)). A calibration curve in artificial serum solution without BSA was 
obtained by plotting the background-subtracted current (both forward and reverse scans) versus 
the RacH+ concentration. The background-subtracted currents on both the forward and reverse 
scans increased proportionally with RacH+ concentrations over the range studied (Fig. 7(c) 
inset).This is in agreement with the result obtained in aqueous LiCl electrolyte.  
In contrast, no RacH+ transfer was observed in artificial serum containing BSA (0.6 mM). A 
small current increment was observed on the forward scan, however no peak-shape feature 
was observed on the reverse scan (Fig. 7 (d)). Since the current signal varied linearly with the 
transferring analyte concentration, these results showed that the concentration of free RacH+ in 
the aqueous phase was extremely low. This result is in agreement with previous studies which 
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demonstrated that the presence of 1 mM BSA in artificial serum decreased the propranolol 
transfer current signal to 6.4 nA, from 9.7 nA in its absence [25].  
In addition, TPrA+ was also spiked into each artificial serum solution (Fig. 7 (e) and (f)). No 
significant shift of the half-wave potential for the TPrA+ ion was observed (𝐸1/2 of 0.52 V) [25]. 
However, the steady-state current for TPrA+ in the presence of BSA decreased from 12.5 (no 
BSA present) to 8.5 nA. A similar observation was also made on the reverse scan, where the 
peak current decreased from 12.9 to 7.9 nA in the absence and presence of BSA, 
respectively. This indicated that BSA adsorbed at the interface and inhibited ion transfer. 
The results presented in this section demonstrate that reduction of the available potential 
window, complexation of the RacH+ by BSA and adsorption of the BSA to the liquid  liquid 
interface, are the possible interference mechanisms for the detection of ractopamine in serum 
via ion-transfer voltammetry. Hence, deproteinisation of samples is necessary for this 




The voltammetric behaviour of the -agonist drug, protonated ractopamine, at a water  DCH 
micro-interface array was investigated. The results show that protonated ractopamine can be 
detected via CV and LSSV. However, this drug transfers at a very positive potential, close to the 
positive limit of the available potential window; nevertheless, estimation of the half-wave 
potential enabled determination of some thermodynamic parameters for this drug, such as the 
Gibbs energy of transfer and the partition coefficient. In addition, a stripping voltammetry 
approach was employed successfully to detect lower concentrations of the drug. The LOD was 
calculated to be 0.1 µM, which is suitable for applications to drug detection in real samples. Of a 
range of potentially interfering substances studied, only potassium ions were found to interfere 
in RacH+ detection, due to its transfer at a potential close to the positive potential limit. 
Additionally, it was found that BSA diminished the ractopamine signal via potential window 
reduction, drug-protein complexation and protein adsorption at the ITIES. The results presented 
here indicate that voltammetry at the micro-ITIES array can be used for detection and 
characterisation of ionised drugs that transfer at high applied potentials but that analysis of 
biological samples will require deproteinisation. In the future, an improved performance, such as 
a lower detection limit, might be achieved with an electrochemical cell that provides a wider 
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Fig. 1. (a) Molecular structure of ractopamine (b) SEM image of the full micropore array silicon 







Fig. 2. Cyclic voltammograms of 20 (light gray) to 100 M (black) RacH+ transfer, in increment of 20 µM 
(a) and its corresponding background-subtracted CV (b) at 5 mV s-1 sweep rate. Inset (a – upper) and 
(b): voltammograms of blank (dotted line) and 100 µM RacH+ with (dashed line) and without (solid black 
line) the addition of TPrA+. Inset (a – lower) is a control experiment with 100 µM MeOH (solid gray line) 
added to the aqueous phase  (c) The corresponding calibration curve of the maximum currents (forward 




Fig. 3. Influence of pre-concentration potentials from 0.6 V (light gray) to 1.0 V (black) in increment of 
0.05 V on the LSSV (background-subtracted) of 20 µM RacH+. The pre-concentration time and sweep 
rate were fixed at 60 s and 5 mV s-1, respectively. Inset: graph of current at selected pre-concentration 





Fig. 4. Influence of pre-concentration times on the LSSV (background-subtracted) of 100 µM RacH+. The 
pre-concentration potential and sweep rate were fixed at 1.0 V and 5 mV s-1, respectively. LSSV 
response of 15 (light gray), 30, 45, 60, 90, 120, 150 and 180 s (black) pre-concentration times. Inset: 





Fig. 5. Background-subtracted LSSV scans of increasing RacH+ concentrations in the aqueous phase 
(indicated by arrow) at the micro-ITIES arrays at 5 mV s-1 sweep rate. LSSV response of 0.1 (light gray), 
0.2, 0.4, 0.6, 0.8 and 1.0 µM (black) drug concentrations. Inset is the calibration curve of stripping peak 








Fig. 6. Electrochemistry of the individual interfering substances at the micro-ITIES arrays. Cyclic 
voltammograms of the blank aqueous phase solution (10 mM LiCl) (black line), the aqueous phase 
spiked with 100 µM RacH+ (dark gray line), the aqueous phase spiked with 100 µM RacH+ and the 
interfering substances (medium gray line), and the aqueous phase spiked with 100 µM RacH+, the 
interfering substances and 100 µM TPrA+ (light gray line). The interfering substances studied: (a) D-
glucose (b) L-ascorbic acid (c) KCl (d) NaCl (e) Na2SO4 (f) glycine (g) urea, and (h) PBS solution in the 
absence of the interfering substance (control). The interfering substance concentration in all cases was 








Fig. 7. Cyclic voltammetry at the micro-ITIES array of an artificial serum solution in the aqueous phase 
((a) and (b)), 100 µM RacH+ in an artificial serum solution ((c) and (d)), and an artificial serum solution of 
100 µM TPrA+ and 100 µM RacH+ ((e) and (f)). Figures (a), (c) and (e) represent cyclic voltammetry of an 
artificial serum without BSA, while figure (b), (d) and (f) represent cyclic voltammetry in the presence of 
0.6 mM BSA. Sweep rate applied was 5 mV s-1. Inset in (c) is the corresponding calibration curve 





Table 1  
Thermodynamic data for the transfer of cationic -agonist drug, protonated ractopamine (RacH+) at the 







 0.29 V (in DCH) 
∆𝐺𝑡𝑟
0′,𝑤→𝐷𝐶𝐻
 27.88 kJ mol
-1 
log 𝑃𝐷𝐶𝐻




a Data obtained from reference [8] 




Table 2  
Influence of potentially interfering substances on the detection of protonated ractopamine (RacH+) at the micro- water  DCH interface array. The 
concentration of RacH+ and interfering substance in all cases were 0.1 mM and 5.0 mM, respectively. In the forward scan, the current was measured 
at the end of the scan, while in the reverse scan the minimum peak current was selected.  
Interfering substance 
 
Forward scan Reverse scan 
𝐼𝑅𝑎𝑐𝐻+ / nA 
(± s; n = 3) 
𝐼(𝑅𝑎𝑐𝐻++𝐼𝑛𝑡𝑒𝑟𝑓𝑒𝑟𝑒𝑛𝑡)  




𝐼𝑅𝑎𝑐𝐻+ / nA  
(± s; n = 3) 
𝐼(𝑅𝑎𝑐𝐻++𝐼𝑛𝑡𝑒𝑟𝑓𝑒𝑟𝑒𝑛𝑡)  




Glucose  9.9 ± 0.17 10.9 ± 0.10 10.3 3.5 ± 0.09 3.7 ± 0.03 6.0 
Ascorbic acid 11.6 ± 0.12 12.6 ± 0.13 9.2 3.5 ± 0.05 3.6 ± 0.02 0.7 
KCl 11.9 ± 0.07 14.1 ± 0.07 19.2 3.4 ± 0.05 3.9 ± 0.01 16.1 
NaCl 9.1 ± 0.10 10.8 ± 0.04 18.9 3.2 ± 0.04 3.3 ± 0.01 3.4 
Na2SO4 9.3 ± 0.16 10.3 ± 0.07 10.7 3.5 ± 0.06 3.8 ± 0.02 7.6 
Glycine 7.6 ± 0.08 8.6 ± 0.01 13.1 2.5 ± 0.06 2.7 ± 0.03 8.8 
Urea 9.0 ± 0.10 9.5 ± 0.08 6.2 2.6 ± 0.08 2.8 ± 0.05 6.1 
PBS 8.4 ± 0.05 8.8 ± 0.03 4.4 2.3 ± 0.05 2.5 ± 0.03 9.6 
Mean (± s; n = 8) 9.6 ± 1.47 - - 3.1 ± 0.52 - - 
s = standard deviation  






× 100 % 
 
 
